RNAi -- From Biology to Therapeutics meeting, Qiagen s BioRobot MDx DSP system, Qiagen s human phosphatase siRNA set and human cancer siRNA set, Wiley s RNA Interference in Practice text | GenomeWeb

C5 has scheduled its upcoming RNAi — From Biology to Therapeutics meeting for Jan. 31-Feb. 1, 2005.

The event, which is taking place at the Kempinski Hotel Bristol in Berlin, is slated to include discussions of such topics as microRNAs in the context of diabetes; RNAi in oncology target validation and discovery; the development of siRNA-based therapeutics; delivery of siRNAs in vivo; and alternative approaches to RNAi to silence genes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.